(Bloomberg) — The final-stage trial of a Chinese frontrunner vaccine candidate has been halted in Brazil due to a serious adverse event, the first time that any of the Asian nations rapidly develope… [+2321 chars]
China Vaccine Trial Halted After Serious Adverse Event – Investing.com
